前往化源商城

N-{2-ethyl-3-oxo-2-azatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4(12),5,7,9-pentaen-9-yl}-2-phenylacetamide

更新时间:2026-04-03 18:08:29

N-{2-ethyl-3-oxo-2-azatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4(12),5,7,9-pentaen-9-yl}-2-phenylacetamide结构式
N-{2-ethyl-3-oxo-2-azatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4(12),5,7,9-pentaen-9-yl}-2-phenylacetamide结构式
委托求购
常用名 N-{2-ethyl-3-oxo-2-azatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4(12),5,7,9-pentaen-9-yl}-2-phenylacetamide 英文名 N-{2-ethyl-3-oxo-2-azatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4(12),5,7,9-pentaen-9-yl}-2-phenylacetamide
CAS号 313405-17-3 分子量 330.4
密度 N/A 沸点 N/A
分子式 C21H18N2O2 熔点 N/A
MSDS N/A 闪点 N/A

 名称

英文名 N-{2-ethyl-3-oxo-2-azatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4(12),5,7,9-pentaen-9-yl}-2-phenylacetamide

 物理化学性质

分子式 C21H18N2O2
分子量 330.4
InChIKey RNAUSYNZIYJVAO-UHFFFAOYSA-N
SMILES CCN1C2=C3C(=C(C=C2)NC(=O)CC4=CC=CC=C4)C=CC=C3C1=O

 靶点实验

查看更多实验

实验名称:Cell-based high throughput primary assay to identify activators of GPR151
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id:GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify activators of...
来源:The Scripps Research Institute Molecular Screening Center
靶标:N/A
External Id:FBW7_ACT_ALPHA_1536_1X%ACT PRUN
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
来源:The Scripps Research Institute Molecular Screening Center
External Id:MITF_INH_Alpha_1536_1X%INH PRUN
共3条,当前第1页,共1页
1
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
我想出现在这里:
QQ交流
351666998 复制
QQ交流二维码
微信交流
13311869306 复制
微信交流二维码

暂无推荐供应商。我要出现这里

相关化合物: 更多...
(5-methyl-2-methylidenehexyl) (Z,2S)-2-hydroxy-6-[(1S,4E,6E,9R,11R,12S,13S,16E,19E,21R,23R,24R)-11-hydroxy-24-(hydroxymethyl)-12,15,21,24-tetramethyl-3-oxo-2,22,26-trioxatricyclo[19.3.1.19,13]hexacosa-4,6,14,16,19-pentaen-23-yl]hex-4-enoate
157075-57-5
(2E,4R,5R,6E,8E,12R)-13-(5-Hydroxy-3,5-dimethyl-4-oxo-4,5-dihydro-2-furanyl)-3,5,9-trimethyl-2,6,8-tridecatriene-4,12-diyl (2S,2'S)bis(3,3,3-trifluoro-2-methoxy-2-phenylpropanoate)
880494-27-9
6aHydroxya9,15adimethyla5,8,11,14,17,21ahexaoxoa19a(propana2ayl)aicosahydroa1Hapyridazino[3,2ao]1aoxaa4,7,10,13,16apentaazacyclononadecana20ayl]a2,3,7atrihydroxya6amethoxya2,8,10,12,14apentamethylhexadeca8aenamide
1818887-79-4
Borate(1-), [2-[[(2,3-dihydroxypropoxy)phosphinyl]oxy]-1-[[[6-[[4-[[4-(dimethylamino)phenyl]azo]benzoyl]amino]-1-oxohexyl]oxy]methyl]ethyl 12-[[5-[5-[(3,5-dimethyl-2H-pyrrol-2-ylidene-I masculineN)methyl]-1H-pyrrol-2-yl-I masculineN]-1-oxopentyl]amino]dodecanoato(2-)]difluoro-, (T-4)
885331-21-5
(2S,3aS,6R,7aS)-N-[4-(hydrazinylmethylideneamino)butyl]-6-hydroxy-1-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxamide
248582-51-6
(alphaR,betaS)-beta-(4-Chlorophenoxy)-alpha-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol
89497-66-5
KnA paragraph signlker complex
243866-64-0
(3R)-N-[1-[[1-[(6,7-dihydroxy-1,1-dimethyl-3,4-dihydro-2H-quinolin-1-ium-3-yl)amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]-3-hydroxy-2-[[3-hydroxy-4-[4-(hydroxymethyl)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-5-yl]butanoyl]amino]butanamide
387816-76-4
11beta-Hydroxysaxitoxin bis(trifluoroacetate)
1923856-43-2
(2R)-N-[(2R)-3-(4-methoxyphenyl)-1-[methyl(propan-2-yl)amino]-1-oxopropan-2-yl]-N,2-dimethyl-3-oxodecanamide
62758-06-9